Stay updated on Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T02:15:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government funding/operating status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:25:22.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center operating status. Updated the site revision to v3.4.1 and removed v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:41:32.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:40:27.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page shows a new site revision: v3.3.4 replacing v3.3.3, a minor update that does not alter core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:38:29.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Locations now appear under a general Locations heading with Washington listed as a site, replacing the former Washington Locations heading. The HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T22:05:36.000Z thumbnail image

Stay in the know with updates to Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.